Biotecnología
Biotecnología
CureVac Names New Chief Business Officer
25/04/2024 -
Thaminda Ramanayake offers more than 15 years of biopharma development and deal-making experience.
Tetra Pharm Technologies & Glysious Partner to Develop Transdermal Combination Drugs
25/04/2024 -
Aim to revolutionize transdermal release of ‘difficult-to-formulate’ compounds targeting the endocannabinoid system.
FDA Approves New Treatment for Uncomplicated Urinary Tract Infections
25/04/2024 -
Today, the FDA approved a new treatment for female adults with uncomplicated urinary tract infections caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus...
Lexeo Enters License Agreement for Friedreich Ataxia Treatment
25/04/2024 -
Aims to expedite development of investigational gene therapy candidate LX2006 for the treatment of FA cardiomyopathy.
FDA Roundup: April 23, 2024
25/04/2024 -
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
BioArctic, Eisai Ink Research Agreement for BAN2802 in AD
25/04/2024 -
To evaluate potential new treatment combining BioArctic's BrainTransporter technology with an undisclosed Alzheimer drug candidate.
Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials
25/04/2024 -
Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials, CBER, Biiologics
Ipsen and Skyhawk Therapeutics Collaborate on RNA Targeting Research
25/04/2024 -
Aim to discover and develop small molecules for the treatment of rare neurological diseases.
Collection of Platelets by Automated Methods
25/04/2024 -
This guidance provides you, blood establishments, and FDA staff with revised recommendations for the collection of Platelets by automated methods (plateletpheresis).
Takeda and Astellas Agree to Establish Joint Venture Company
25/04/2024 -
New joint venture aims to cover the entire drug discovery process, spanning early drug discovery research through the inception of drug discovery startups.
AI assistants for cancer patients
25/04/2024 -
In this interview, Belong.Life (NY, USA) co-founders Irad Deutsch and Eliran Malki explore how AI assistants can be used to...
Drug Development Considerations for the Treatment of Congenital Cytomegalovirus Infection and Neonatal Enterovirus Infection - 05/07/2024
25/04/2024 -
The Food and Drug Administration is holding a public, two-day workshop entitled Development of Drugs for the Treatment of Congenital Cytomegalovirus (CMV) Infection and Neonatal Enterovirus Infection.
2024 Compounding Quality Center of Excellence Annual Conference - 08/21/2024
25/04/2024 -
The FDA Compounding Quality Center of Excellence will host its fifth Annual Conference, Aug. 21-23. This hybrid event provides an opportunity for outsourcing facilities and others to learn and build...
SystImmune Names New CEO
25/04/2024 -
Taps former Bristol Myers Squibb exec with 20 years’ experience in the biopharmaceutical industry.
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer
25/04/2024 -
On April 18, 2024, the Food and Drug Administration approved alectinib (Alecensa, Genentech, Inc.) for adjuvant treatment following tumor resection in patients with anaplastic lymphoma kinase...
Considerations for Plasmid DNA Vaccines for Infectious Disease Indications
25/04/2024 -
Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications, final, vaccines
Calluna Names Senior Vice President of Clinical Operations & Pharmacovigilance
25/04/2024 -
Margrethe Sørgaard offers 25 years’ experience in leading positions in clinical development and operation, medical affairs and drug safety/pharmacovigilance.
SPIKEVAX
25/04/2024 -
COVID19 Vaccine, mRNA
Emotionally intelligent AI agents for VR medical training
25/04/2024 -
Emotions significantly influence human-computer interactions, yet the design of emotionally intelligent agents in educational simulations has been largely unexplored, especially in...
BigHat Biosciences Partners with Janssen Biotech to Guide Antibody Discovery & Design
25/04/2024 -
Collaboration will combine the drug discovery, clinical development and data science expertise from Johnson & Johnson with BigHat’s AI/ML platform.
Genentech's Alecensa Approved in Early-Stage NSCLC
22/04/2024 -
Phase III ALINA study demonstrates Alecensa reduced the risk of disease recurrence or death by 76%.
